JP2018526351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526351A5 JP2018526351A5 JP2018506262A JP2018506262A JP2018526351A5 JP 2018526351 A5 JP2018526351 A5 JP 2018526351A5 JP 2018506262 A JP2018506262 A JP 2018506262A JP 2018506262 A JP2018506262 A JP 2018506262A JP 2018526351 A5 JP2018526351 A5 JP 2018526351A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- solid solution
- solution pharmaceutical
- composition according
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/821,687 | 2015-08-07 | ||
| US14/821,687 US9744132B2 (en) | 2010-10-29 | 2015-08-07 | Solid solution compositions and use in chronic inflammation |
| EP15180256.8A EP3127556A1 (en) | 2015-08-07 | 2015-08-07 | Solid solution compositions for nsaid |
| EP15180256.8 | 2015-08-07 | ||
| PCT/EP2016/068900 WO2017025517A1 (en) | 2015-08-07 | 2016-08-08 | SOLID SOLUTION COMPOSITIONS FOR NSAIDs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018526351A JP2018526351A (ja) | 2018-09-13 |
| JP2018526351A5 true JP2018526351A5 (enExample) | 2019-09-12 |
| JP6989489B2 JP6989489B2 (ja) | 2022-01-05 |
Family
ID=56800263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018506262A Active JP6989489B2 (ja) | 2015-08-07 | 2016-08-08 | Ｎｓａｉｄのための固溶体組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP3331568B1 (enExample) |
| JP (1) | JP6989489B2 (enExample) |
| CN (1) | CN108025078A (enExample) |
| AU (1) | AU2016306610B2 (enExample) |
| CA (1) | CA2994899C (enExample) |
| ES (2) | ES2906571T3 (enExample) |
| IL (1) | IL257385A (enExample) |
| MX (1) | MX387217B (enExample) |
| PL (1) | PL3331568T3 (enExample) |
| WO (1) | WO2017025517A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| AU2022248850A1 (en) | 2021-03-27 | 2023-11-09 | TRx Biosciences Limited | Compositions having improved bioavailability of therapeutics |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| US9308213B2 (en) * | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US10695432B2 (en) * | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| CN105007947B (zh) * | 2013-01-14 | 2019-02-15 | 因佛斯特医疗有限公司 | 固溶体组合物及其在心血管疾病中的用途 |
-
2016
- 2016-08-08 ES ES16756963T patent/ES2906571T3/es active Active
- 2016-08-08 EP EP16756963.1A patent/EP3331568B1/en active Active
- 2016-08-08 EP EP21214529.6A patent/EP3988091B1/en active Active
- 2016-08-08 CA CA2994899A patent/CA2994899C/en active Active
- 2016-08-08 MX MX2018001584A patent/MX387217B/es unknown
- 2016-08-08 AU AU2016306610A patent/AU2016306610B2/en active Active
- 2016-08-08 JP JP2018506262A patent/JP6989489B2/ja active Active
- 2016-08-08 PL PL16756963T patent/PL3331568T3/pl unknown
- 2016-08-08 ES ES21214529T patent/ES3057447T3/es active Active
- 2016-08-08 CN CN201680054597.5A patent/CN108025078A/zh active Pending
- 2016-08-08 WO PCT/EP2016/068900 patent/WO2017025517A1/en not_active Ceased
-
2018
- 2018-02-07 IL IL257385A patent/IL257385A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506941A5 (enExample) | ||
| JP2016504403A5 (enExample) | ||
| MX2018001584A (es) | Composiciones de solución sólida para aines. | |
| EP3355874A4 (en) | TOPICAL ANALGETIC FORMULATIONS, MANUFACTURE AND METHOD FOR USE THEREOF | |
| JP2017105763A5 (enExample) | ||
| RU2017115772A (ru) | Комбинация для генотерапии | |
| LU92578B1 (fr) | Nouveaux composés et compostions pharmaceutiques de ceux-ci pour le traitement de la mucoviscidose | |
| PE20180931A1 (es) | Metodo de cristalizacion y biodisponibilidad | |
| DK3793534T3 (da) | Oral tablet til levering af aktive ingredienser til mavetarmkanalen | |
| BR112015030315A2 (pt) | derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo | |
| EA202192322A1 (ru) | Фармацевтические составы | |
| MA39443A1 (fr) | Nouvelle formulation de méloxicam | |
| AR108712A1 (es) | (5r)-5-[3-[(3s)-4-(4-cloro-3-metoxi-5-metil-fenil)-3-metil-piperazin-1-il]-3-oxo-propil]-5-metil-imidazolidin-2,4-diona, composiciones farmacéuticas del mismo para el tratamiento de trastornos inflamatorios y osteoartritis | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| MX386521B (es) | Composiciones farmaceuticas que contienen un relajante muscular y un antiinflamatorio no esteroideo (aine). | |
| EA202091603A1 (ru) | Фармацевтические композиции на основе ментилового эфира индометацина и их применение в качестве противовоспалительных средств | |
| AR101227A1 (es) | Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor | |
| TR201908031T4 (tr) | İdrar kesesi hastalıklarının tedavisine yönelik muskarinik m3 ligandları olarak 2-aminotiyazol türevleri veya bunların tuzu. | |
| WO2015166418A3 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
| RU2017113827A (ru) | Фармацевтический состав для уменьшения спазмов мочевого пузыря и способ его применения | |
| MX2013008993A (es) | Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide. | |
| EA201790089A1 (ru) | Фармацевтические средства для лечения головокружения различной этиологии | |
| UA120075C2 (uk) | Фармацевтична композиція для лікування запальних змін прямої кишки | |
| RU2016131412A (ru) | Применение парикальцитола для лечения воспалительной анемии | |
| TW201611830A (en) | Pharmaceutical formulation for reducing bladder spasms and method of use thereof |